Home/Judging a Fair Trial: How Clinicians Decide When a Depression Medicine Has Had Its Chance
02Treatment Planning

Judging a Fair Trial: How Clinicians Decide When a Depression Medicine Has Had Its Chance

A medicine that did not lift your mood is not always a medicine that was wrong for you, and knowing how clinicians sort those cases makes your next visit easier.

A plain-language guide, reviewed against current clinical guidance · Updated 2026

When an antidepressant leaves you feeling no better, it makes sense to ask whether the medication failed. Clinicians generally focus on a more precise set of questions. Did the person receive a genuine trial, with a dose high enough and a duration long enough to show its effect, and were the instructions followed? The answers guide the next step, which might be changing to a different drug, modifying the dose, adding another medication, or opting for a treatment that doesn't come as a pill or capsule.

What a fair trial usually includes

A fair trial has three working parts. The first is dose. Many antidepressants are started low and raised over time, partly to limit side effects. If a medicine was stopped while the dose was still being adjusted, the trial may never have reached the level where it could help. Ask your prescriber what dose you have actually been taking and whether it has been raised to the usual target range for that medicine.

The second part is time. Most antidepressants take several weeks before benefits become clear, and some people notice early changes in sleep or appetite before mood shifts. Clinicians often set a checkpoint in advance, a date by which they expect some movement. That checkpoint is not arbitrary, but the right length varies by medicine and by the person taking it, so confirm it with your own clinician rather than assuming.

The third part is whether you actually took it. Missed doses, pharmacy gaps, cost problems, and stopping early because of side effects all shorten a trial without anyone deciding the medicine was wrong. Being honest about this is not a confession. It is information that changes how the result should be read. A medicine taken irregularly for a month has not had the same test as one taken daily at the target dose.

Reading a result that is only partly good

Sometimes a trial produces a mixed picture. Sleep may improve while energy stays low. Anxiety may ease while interest in daily activities does not come back. Mixed results are common enough that clinicians plan for them, but they can be hard to interpret from the inside. When change is partial, the useful question is which symptoms moved, which did not, and whether the pattern held steady or faded over time.

Partial change can point in more than one direction. It may mean the medicine is doing some of its work and needs more time or a higher dose. It may mean the medicine is helping one part of the illness, and a different approach is needed for the rest. Clinicians weigh these possibilities against side effects, how you feel about continuing, and which other options are realistic for your situation. You do not need to reach the conclusion yourself, but describing the pattern clearly helps your clinician reach a sound one.

What to bring to the conversation

Keeping a brief log simplifies that discussion considerably. Record the drug name, the amount taken, when you began, any adjustments to the amount, and approximately how many doses you skipped. Beside those entries, write down in everyday language what you observed each week. Entries such as "mornings are worse" or "I get through work, but by evening nothing feels enjoyable" offer a doctor concrete detail, rather than a vague impression that nothing has changed.

Side effects belong on the same page. Write down what happened, when it started, and whether it eased. Do not drop them from the record because they felt minor or because you were embarrassed to mention them.

Then ask direct questions. What would make this a fair trial in my case? How long should we wait before deciding? If we stop here, what are the realistic next steps, and what does each one ask of me in time, travel, and cost? Asking these early means you are not learning the answers in a rush when a decision is already due.

Keeping the goal in view

The purpose of judging a trial is not to assign blame to a medicine or to you. It is to make a shared, honest call about what to try next. Some people find the first medicine was a poor fit. Others find it came close and needed more time or a different dose. Both outcomes are useful, and both lead to a clearer next step when the evidence is laid out plainly.

If you live in the St. Louis area and are weighing whether a trial has run its course, bring your notes to the next visit and treat the conversation as a working session. The aim is a decision you understand, not one you accepted under pressure.

In crisisCall or text 988 (Suicide & Crisis Lifeline), any time. This site is information, not emergency care.